Literature DB >> 18855845

Effects of tigecycline and daptomycin on murine gut colonization by Candida albicans.

George Samonis1, Elpis Mantadakis, Emmanouel Barbounakis, Diamantis Kofteridis, George Papadakis, Loukia Sifaki, Sofia Maraki.   

Abstract

Adult male Crl:CD1 (ICR) BR mice were fed chow containing Candida albicans or regular chow. Both groups were subsequently given tigecycline or daptomycin or normal saline subcutaneously for 10 days. To determine the effect on the stool yeast concentration, stool cultures were performed immediately before, at the end, and 1 week after discontinuation of treatment. Candida-colonized mice treated with tigecycline or daptomycin had higher counts of the yeast in their stools than control C. albicans-colonized animals treated with saline. Tigecycline caused a significant increase of 2.1 log(10) CFU g(-1) of stools in C. albicans concentration, while daptomycin caused a minor increase of 0.4 log(10) CFU g(-1) of stools. Mice fed regular chow and treated with the study antibiotics or saline did not have any Candida in their stools. Dissemination of Candida was not detected in any animal. These data suggest that tigecycline induces a substantial increase in the intestinal concentration of C. albicans, while daptomycin causes only a minimal increase. However, these increases are not associated with dissemination of the yeast to internal organs. Clinical studies in humans are needed to validate our findings, especially in patients at risk of developing disseminated candidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855845     DOI: 10.1111/j.1439-0507.2008.01500.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species.

Authors:  Matthaios Papadimitriou-Olivgeris; Anastasia Spiliopoulou; Fotini Fligou; Iris Spiliopoulou; Lora Tanaseskou; Georgios Karpetas; Markos Marangos; Evangelos D Anastassiou; Myrto Christofidou
Journal:  Infection       Date:  2017-07-29       Impact factor: 3.553

2.  Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype.

Authors:  Kathleen Romanowski; Alexander Zaborin; Vesta Valuckaite; Ronda J Rolfes; Trissa Babrowski; Cindy Bethel; Andrea Olivas; Olga Zaborina; John C Alverdy
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

3.  An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen.

Authors:  Valerie J Morley; Clare L Kinnear; Derek G Sim; Samantha N Olson; Lindsey M Jackson; Elsa Hansen; Grace A Usher; Scott A Showalter; Manjunath P Pai; Robert J Woods; Andrew F Read
Journal:  Elife       Date:  2020-12-01       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.